Top Stocks
Daily Feeds
Tools
Calendars
Research Tools
My Portfolio
My Watchlists
Profile & Performance
Find & Follow Experts
Top Lists
Top Experts
Categories
Trending Topics
News
Make Better, Data Driven Investment Decisions
TipRanks tools are all you need to make data-driven investment decisions, conduct comprehensive stock research, find new investment ideas, analyze your portfolio, and follow the best-performing Wall Street experts.About us
TipRanks For Business
Company Policy
About Us
Expert CenterTop Wall Street AnalystsTop Financial BloggersTop Corporate InsidersTop Hedge Fund ManagersTop Individual InvestorsTop Performing Research Firms
Stock Comparison5g StocksAirline StocksArtificial Intelligence StocksBank StocksBiotech StocksBitcoin StocksBlockchain StocksBlue Chip StocksCannabis StocksCasino StocksChinese StocksCoronavirus Therapeutics StocksCoronavirus Vaccine StocksCryptocurrency StocksCybersecurity StocksElectric Vehicle StocksFAANG StocksGold StocksGrowth StocksHealthcare StocksHigh Dividend StocksHotel StocksLarge Cap StocksMega Cap StocksNFT StocksOil StocksOutdoor Activities StocksRenewable Energy StocksSolar StocksSpace StocksStay-At-Home StocksTech StocksUtility StocksVideo Game StocksVirtual Reality StocksWallStreetBets StocksWork-From-Home Stocks
Verrica Pharmaceuticals (VRCA)
NASDAQ:VRCA
Verrica Pharmaceuticals Stock Analysis & Ratings
Verrica Pharmaceuticals Stock Analysis Overview
Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
ANALYST RATINGS
CONSENSUS
Strong Buy
Average Price Target : $18.80
BLOGGER OPINIONS
SENTIMENT
N/A
Currently Not Enough Data Available
HEDGE FUND ACTIVITY
TREND
N/A
Currently Not Enough Data Available
INSIDER ACTIVITY
TREND
▲ Bought Shares
Worth $467.9K over the Last 3 Months
TIPRANKS INVESTORS
SENTIMENT
Very Negative
Last 7 Days >0.1% Last 30 Days ▼10.4%
NEWS SENTIMENT
LAST 7 DAYS
N/A
Currently Not Enough Data Available
TECHNICALS
SMA
Negative
20 days / 200 days
MOMENTUM
0.50%
12 Months Change
FUNDAMENTALS
RETURN ON EQUITY
-95.72%
Trailing 12 Months
ASSET GROWTH
10.42%
Trailing 12 Months
VRCA Stock Stats
Previous Close$9.26
Open$9.48
Bid9 x 99
Ask13.98 x 40
Today’s Range$9.26 - $10.08
52-Week Range$8.51 - $18.42
Volume122.47K
Average Volume106.41K
Market Cap$274.36M
Beta2.09
P/E Ratio-6.3
EPS-1.46
Earnings DateMar 10, 2022
1Y Price Target$18.80
Company Description
Verrica Pharmaceuticals
Financials
P/E Ratio Range
The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.
Verrica Pharmaceuticals News
VRCA FAQ
What was Verrica Pharmaceuticals’s price range in the past 12 months?
Verrica Pharmaceuticals lowest stock price was $8.51 and its highest was $18.42 in the past 12 months.
What is Verrica Pharmaceuticals’s market cap?
Verrica Pharmaceuticals’s market cap is $274.36M.
What is Verrica Pharmaceuticals’s price target?
The average price target for Verrica Pharmaceuticals is $18.80. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $20.00 ,the lowest forecast is $16.00. The average price target represents 88.57% Increase from the current price of $9.97.
The highest analyst price target is $20.00 ,the lowest forecast is $16.00. The average price target represents 88.57% Increase from the current price of $9.97.
What do analysts say about Verrica Pharmaceuticals?
Verrica Pharmaceuticals’s analyst rating consensus is a ‘Strong Buy. This is based on the ratings of 5 Wall Streets Analysts.
When is Verrica Pharmaceuticals’s upcoming earnings report date?
Verrica Pharmaceuticals’s upcoming earnings report date is Mar 10, 2022 which is in 93 days.
How were Verrica Pharmaceuticals’s earnings last quarter?
Verrica Pharmaceuticals released its earnings results on Nov 12, 2021. The company reported -$0.47 earnings per share for the quarter, beating the consensus estimate of -$0.51 by $0.04.
Is Verrica Pharmaceuticals overvalued?
According to Wall Street analysts Verrica Pharmaceuticals’s price is currently Undervalued.
Does Verrica Pharmaceuticals pay dividends?
Verrica Pharmaceuticals does not currently pay dividends.
What is Verrica Pharmaceuticals’s EPS estimate?
Verrica Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Verrica Pharmaceuticals have?
Verrica Pharmaceuticals has 27,520,000 shares outstanding.
What happened to Verrica Pharmaceuticals’s price movement after its last earnings report?
Verrica Pharmaceuticals reported an EPS of -$0.47 in its last earnings report, beating expectations of -$0.51. Following the earnings report the stock price went down -4.216%.
Which hedge fund is a major shareholder of Verrica Pharmaceuticals?
Among the largest hedge funds holding Verrica Pharmaceuticals’s share is Perceptive Advisors LLC. It holds Verrica Pharmaceuticals’s shares valued at 45M.